Texas A&M Stakes Claim as Leader in Pharmaceuticals

One hundred miles from the nearest major city, where there was nothing but flat earth seven months ago, a 145,000-square-foot facility has sprung up on the Texas A&M Health Science Center campus. Starting in January, its cavernous rooms will be filled with racks of tobacco-like plants expected to produce as many influenza vaccines in a single month as a traditional lab does in one year, at a fraction of the cost.

Dr. Brett Giroir, the vice chancellor for research at the Texas A&M University System, calls it the most exciting project of its kind in the world ...

Full Story

Comment Policy

The Texas Tribune is pleased to provide the opportunity for you to share your observations about this story. We encourage lively debate on the issues of the day, but we ask that you refrain from using profanity or other offensive speech, engaging in personal attacks or name-calling, posting advertising, or wandering away from the topic at hand. To comment, you must be a registered user of the Tribune, and your user name will be displayed. Thanks for taking time to offer your thoughts.

You must be logged in to leave a comment. Login | Sign-Up